XML 58 R65.htm IDEA: XBRL DOCUMENT v3.20.1
Subsequent Events (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
May 14, 2020
Mar. 31, 2020
Dec. 30, 2019
Dec. 27, 2019
May 14, 2020
Apr. 30, 2020
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Subsequent Event [Line Items]                  
Debt issued             $ 113,700 $ 0 $ 0
Subsequent Event                  
Subsequent Event [Line Items]                  
Proceeds from regulatory milestone payments           $ 10,000      
Majority Shareholder | Sumitomo Dainippon Pharma, Co., Ltd.                  
Subsequent Event [Line Items]                  
Number of shares owned (in shares)   46,788,604   45,008,604          
Ownership percentage   52.10%   50.20%          
Majority Shareholder | Sumitomo Dainippon Pharma, Co., Ltd. | Subsequent Event                  
Subsequent Event [Line Items]                  
Number of shares issued (in shares)         1,679,868        
Number of shares owned (in shares) 48,468,472                
Ownership percentage 53.90%                
Term Loan | Majority Shareholder | Letter Agreement with Sumitomo Dainippon Pharma, Co., Ltd. | Sumitomo Dainippon Pharma, Co., Ltd.                  
Subsequent Event [Line Items]                  
Debt issued     $ 113,700            
Available borrowing capacity   $ 286,300         $ 286,300    
Term Loan | Majority Shareholder | Letter Agreement with Sumitomo Dainippon Pharma, Co., Ltd. | Sumitomo Dainippon Pharma, Co., Ltd. | Subsequent Event                  
Subsequent Event [Line Items]                  
Debt issued           80,000      
Available borrowing capacity           $ 206,300